Primary Liver Cancer
What's New
Last Posted: Jun 12, 2024
- Deep learning models for predicting the survival of patients with hepatocellular carcinoma based on a surveillance, epidemiology, and end results (SEER) database analysis.
Shoucheng Wang et al. Sci Rep 2024 14(1) 13232 - Gene therapy for people with hepatocellular carcinoma.
Cho Naing et al. Cochrane Database Syst Rev 2024 6(6) CD013731 - Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma
J Xu et al, JPM, April 15, 2024 - Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model.
Honghong Shen et al. Journal of hepatocellular carcinoma 2023 10327-345 - DLNLF-net: Denoised local and non-local deep features fusion network for malignancy characterization of hepatocellular carcinoma.
Huang Haoyuan et al. Computer methods and programs in biomedicine 2022 227107201 - Development and Validation of Nomogram for Predicting Survival of Primary Liver Cancers Using Machine Learning.
Chen Rui et al. Frontiers in oncology 2022 12926359 - Computer-aided diagnosis of hepatocellular carcinoma fusing imaging and structured health data.
Menegotto Alan Baronio et al. Health information science and systems 2021 9(1) 20 - Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine.
Dercle Laurent et al. European journal of radiology 2020 Jan 125108850 - The evolving landscape of precision medicine in primary liver cancer.
Martin Sean P et al. Hepatic oncology 2019 Jun 6(2) HEP12 - Novel translational therapeutic strategy by sequencing primary liver cancer genomes.
Glantzounis Georgios K et al. Future oncology (London, England) 2017 13(12) 1049-1052
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: